You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Details for New Drug Application (NDA): 021695

✉ Email this page to a colleague

NDA 021695 describes ANTARA (MICRONIZED), which is a drug marketed by Lupin and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the ANTARA (MICRONIZED) profile page.

The generic ingredient in ANTARA (MICRONIZED) is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.

Summary for 021695

Tradename:	ANTARA (MICRONIZED)
Applicant:	Lupin
Ingredient:	fenofibrate
Patents:	2

Pharmacology for NDA: 021695

Medical Subject Heading (MeSH) Categories for 021695

Hypolipidemic Agents

Suppliers and Packaging for NDA: 021695

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ANTARA (MICRONIZED)	fenofibrate	CAPSULE;ORAL	021695	NDA	Lupin Pharmaceuticals, Inc.	27437-109	27437-109-06	30 CAPSULE in 1 BOTTLE (27437-109-06)
ANTARA (MICRONIZED)	fenofibrate	CAPSULE;ORAL	021695	NDA	Lupin Pharmaceuticals, Inc.	27437-110	27437-110-06	30 CAPSULE in 1 BOTTLE (27437-110-06)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	43MG
Approval Date:	Nov 30, 2004	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	CAPSULE;ORAL			Strength	87MG
Approval Date:	Nov 30, 2004	TE:		RLD:	No

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	130MG
Approval Date:	Nov 30, 2004	TE:	AB	RLD:	Yes

Expired US Patents for NDA 021695

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lupin	ANTARA (MICRONIZED)	fenofibrate	CAPSULE;ORAL	021695-003	Nov 30, 2004	7,863,331	⤷ Get Started Free
Lupin	ANTARA (MICRONIZED)	fenofibrate	CAPSULE;ORAL	021695-001	Nov 30, 2004	7,863,331	⤷ Get Started Free
Lupin	ANTARA (MICRONIZED)	fenofibrate	CAPSULE;ORAL	021695-004	Oct 18, 2013	8,026,281	⤷ Get Started Free
Lupin	ANTARA (MICRONIZED)	fenofibrate	CAPSULE;ORAL	021695-002	Nov 30, 2004	7,863,331	⤷ Get Started Free
Lupin	ANTARA (MICRONIZED)	fenofibrate	CAPSULE;ORAL	021695-002	Nov 30, 2004	4,800,079	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.